SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000059478-20-000185
Filing Date
2020-12-03
Accepted
2020-12-03 21:00:45
Documents
1
Period of Report
2020-12-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_160704722837838.html 3  
1 FORM 3 wf-form3_160704722837838.xml 3 4103
  Complete submission text file 0000059478-20-000185.txt   5872
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Reporting) CIK: 0000059478 (see all company filings)

State of Incorp.: IN | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39746 | Film No.: 201368410
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 617-336-7540
Sigilon Therapeutics, Inc. (Issuer) CIK: 0001821323 (see all company filings)

IRS No.: 474005543 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations